MedTrace Logo

Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery

NCT03997162 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2026-02-24

No results posted yet for this study

Summary

This phase II trial studies how well an early recovery after surgery protocol works in enhancing quality of life in participants with stage 0-IIIC gastric cancer undergoing surgery. The early recovery after surgery protocol may decrease pain and nausea, promote bowl function, decrease the number of days hospitalized, and improve a participant's ability to function normally after surgery.

Conditions

  • Clinical Stage 0 Gastric Cancer AJCC v8
  • Clinical Stage I Gastric Cancer AJCC v8
  • Clinical Stage II Gastric Cancer AJCC v8
  • Clinical Stage IIA Gastric Cancer AJCC v8
  • Clinical Stage IIB Gastric Cancer AJCC v8
  • Clinical Stage III Gastric Cancer AJCC v8
  • Gastric Adenocarcinoma
  • Pathologic Stage 0 Gastric Cancer AJCC v8
  • Pathologic Stage I Gastric Cancer AJCC v8
  • Pathologic Stage IA Gastric Cancer AJCC v8
  • Pathologic Stage IB Gastric Cancer AJCC v8
  • Pathologic Stage II Gastric Cancer AJCC v8
  • Pathologic Stage IIA Gastric Cancer AJCC v8
  • Pathologic Stage IIB Gastric Cancer AJCC v8
  • Pathologic Stage III Gastric Cancer AJCC v8
  • Pathologic Stage IIIA Gastric Cancer AJCC v8
  • Pathologic Stage IIIB Gastric Cancer AJCC v8
  • Pathologic Stage IIIC Gastric Cancer AJCC v8

Interventions

OTHER

Best Practice

Complete standard of care enhanced recovery after surgery protocol

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Yanghee Woo · City of Hope Medical Center

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-11
Primary Completion
2023-01-18
Completion
2027-01-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03997162 on ClinicalTrials.gov